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Abstract
ECMO, or extracorporeal membrane oxygenation, is an advanced life support 
technique that provides cardiac and pulmonary support similar to cardiopulmonary 
bypass. ECPR (extracorporeal cardiopulmonary resuscitation) is the rapid deploy-
ment of VA-ECMO when conventional cardiopulmonary resuscitation fails to 
provide return of spontaneous circulation. Evidence in the literature is sparse, but 
with expanding reported applications, ECPR has shown promise to improve out-
comes of cardiac arrest. ECPR is superior to conventional CPR for both survival and 
neurologic outcomes. ECPR has been successfully used to manage arrests secondary 
to cardiac and non-cardiac causes. Arrests secondary to primary cardiac causes have 
the best overall outcome. Other determinants of outcomes of ECPR include dura-
tion of low flow state and on-ECMO complications. A narrow list of ECPR contra-
indications exists, and includes severe neurologic injury and irreversible primary 
disease process. Various complications can occur with ECPR, and include mechani-
cal, cardiovascular, pulmonary, hematologic, renal, and neurologic complications. 
Neurologic complications are the most serious, and significantly affect mortality 
or quality of life. ECPR is a nascent field, and substantial work remains to be done 
to optimize its application. Given the small number of patients at each institutional 
level, this is a field ripe for collaborative work and rewarding results.
Keywords: extracorporeal membrane oxygenation, cardiopulmonary resuscitation, 
ECPR, cardiac arrest
1. Background
ECMO, or extracorporeal membrane oxygenation, is an advanced life support 
technique that provides cardiac and pulmonary support similar to cardiopulmo-
nary bypass. Venous blood is drained and pumped through a membrane where gas 
exchange occurs. Oxygenated blood is returned back to the patient either through 
venous circulation in VV-ECMO (venovenous ECMO) or arterial circulation in 
VA-ECMO (venoarterial ECMO).
ECPR (extracorporeal cardiopulmonary resuscitation) is the rapid deployment 
of VA-ECMO during cardiopulmonary resuscitation (CPR) when conventional CPR 
fails to provide return of spontaneous circulation (ROSC) [1]. The first reported 
use of ECMO in CPR was in 1976. Since then, the use of ECPR has become well-
described in adults and children, with a continuously expanding list of diagnoses.
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ECPR literature is limited, more so for pediatrics. Reports are mainly single 
center experiences, registry retrospective analyses, and a few meta-analyses. Small 
sample sizes and lack of standardization impede drawing conclusions on utilization 
and care processes for ECPR. Regardless, utilization of ECPR continues to expand. 
The Extracorporeal Life Support Organization (ELSO) reports more than a total of 
10,000 ECPR patients since 1990, of which more than 5000 are pediatric or neonatal 
runs [2]. ECPR cases make up approximately 10% of all ECMO runs recorded over 
this time frame. Most ECPR cases originate in the intensive care unit, but there is 
growing literature demonstrating widening the use to emergency room arrests and 
out-of-hospital arrests [3, 4].
With expanding application, ECPR has shown promise to improve outcomes of 
cardiac arrest. ELSO recognizes that ECMO can be considered for select patients in 
cardiac arrest. In 2015, the American Heart Association (AHA) cautiously pointed 
out that while the evidence is still lacking, ECPR may reasonably be considered in 
potentially reversible situations [5].
This chapter explores the current utility of ECPR, and provides a literature 
summary of its indications and limitations. The chapter will also describe current 
use and outcomes in adults and children. Finally, complications of ECPR will be 
reviewed. A special focus will highlight neurologic complications and their influ-
ence on meaningful outcomes after ECPR.
2. ECPR is superior to conventional CPR
ECPR use for victims of cardiac arrest consistently demonstrates a survival ben-
efit over conventional CPR [5–8]. This survival benefit is more pronounced as the 
duration of CPR increases. In contrast to arrest survivors who only receive conven-
tional CPR, patients rescued with ECPR have higher survival rates at discharge and 
at 6-12 months post discharge [9]. Arrest victims rescued with ECPR are also more 
likely to have better neurologic outcome, when compared to patients rescued with 
conventional CPR [10].
3. Indications
The goal of ECPR is to augment cardiac output during the low flow phase of 
CPR, restoring oxygenation and perfusion in the setting of cardiac arrest. In some 
cases ECPR alone may be therapeutic, and in other cases it allows maintenance of 
perfusion while further treatment is explored.
At this time, no universal criteria exist for the deployment of ECPR. AHA recom-
mendations are limited to heart disease amenable to either recovery or transplantation, 
in a setting where the arrest occurs in a highly supervised environment [11]. Their only 
other recommendation is for use in out of hospital cardiac arrest in the setting of severe 
hypothermia if appropriate expertise, equipment, and protocols are available. ELSO 
recommends ECPR in arrest victims “with an easily reversible event and have had excel-
lent CPR” [12]. The UK Resuscitation Council considers ECPR as a “rescue therapy for 
patients in whom initial ALS measures are unsuccessful to facilitate specific interven-
tions” such as coronary interventions or thrombectomies [13].
Centers that offer ECPR use center-specific processes, based on experience and 
availability of resources. ECPR is most commonly available to in-hospital cardiac 
arrest. Arrests in the emergency department can also be managed with ECPR. In 
some settings with appropriate resources, experience, and planning, out-of-hospital 
cardiac arrest has been managed with out-of-hospital ECPR [4, 14].
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4. Contraindications
Contraindications to ECPR vary between institutions, and a unified consen-
sus does not exist. ECMO-related prognostic factors in the current literature are 
unreliable with regards to ECPR outcomes. On their own, most of these factors do 
not provide sufficient evidence to support denial of life-saving ECPR to a victim of 
arrest. The only absolute contraindications to ECPR are the presence of a valid “Do 
Not Resuscitate” order and the absence of appropriate staff/equipment to initiate 
ECPR. All contraindications to ECMO use, such as extreme prematurity, also apply.
Otherwise, a range of situations can be proposed as relative contraindications 
for ECPR:
1. Severe neurological impairment prior to cardiac arrest: Exact definitions 
of impairment will vary between providers and institutions. In a similar 
vein, conditions that place a patient at high risk for severe neurologic 
injury despite good CPR (such as severe primary pulmonary hypertension 
or patients with cavopulmonary circulation) may be a reason to not offer 
ECPR. Determinations to preclude a child from ECMO candidacy may involve 
a discussion with family, and should contain an understanding the perceived 
and expected quality of the child’s life.
2. Known irreversible disease process: When cardiac arrest occurs in the set-
ting of a known irreversible and untreatable disease process, ECPR will only 
prolong suffering. Providers must work with the appropriate subspecialists 
to understand primary disease prognosis in order to determine if ECPR is an 
appropriate choice should the patient arrest.
3. Severe immunosuppressed state: While literature is limited, certain groups of 
severely immunocompromised patients tend to do worse on ECMO. Patients 
with immunosuppression in the setting of solid organ transplantation or high-
dose steroid regimens may have outcomes comparable to the general popula-
tion. In contrast, patients with solid tumors, hematological malignancies, or 
acquired immunodeficiency syndrome (AIDS) do much worse on ECMO. In 
one study, survival to discharge was 7–20% [15]. This highlights the need to 
understand primary disease prognosis, and determine ECMO candidacy prior 
to arrest.
4. Severe coagulopathy: Management of ECMO post-resuscitation requires use 
of anticoagulation to maintain appropriate circuit function. In cases of severe 
coagulopathy, the physician must balance the management of the coagulopa-
thy and the circuit anticoagulation. If the coagulopathy is difficult to treat, 
devastating and fatal hemorrhagic side effects may occur [16].
5. Prolonged total arrest time: There is no consensus on a cut-off time, but 
as shown in Figure 1, prolonged low-flow states are associated with lower 
survival [17]. Neurologic outcomes are also worse. The impact is magnified if 
combined with failure to initiate chest compressions in a timely fashion after 
arrest. While a prolonged resuscitation may be not futile, each institution must 
consider its capabilities and available resources before establishing a cutoff 
time. This decision will also likely be patient-dependent.
6. Lack of access for cannulation: Anatomic or other vascular anomalies that 
preclude successful cannulation render a patient a non-candidate for ECPR.
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5. The ECPR experience
According to recent reviews of the ELSO registry, ECPR is currently most 
commonly used in patients who suffer cardiac arrest secondary to a primary cardiac 
cause [7]. This is independent from patients who fail to wean off cardiopulmonary 
bypass. These patients include arrests post cardiac surgery, such as surgery for 
congenital heart disease (CHD). CHD patients rescued with ECPR include both 
single and two-ventricle patients. This cardiac cohort also includes patients with 
structurally normal hearts but develop heart failure in the setting of myocarditis, 
cardiomyopathy, arrhythmias, pulmonary arterial hypertension, and heart trans-
plant graft failures.
A variety of non-cardiac causes of arrest have also been supported by 
ECPR. These include arrests in the setting of septic and other forms of non- 
cardiogenic shock. Arrests that occur in the setting of pneumonia, ARDS, acute 
airway compromise, toxic ingestions, severe hypothermia, and trauma have also 
been supported with ECPR.
In some situations where the cause of arrest is unclear, ECPR allows for preserv-
ing the patient while the diagnosis can be clarified. For example, ECMO support 
allows for time to perform head imaging or other diagnostic testing that helps with 
clarifying treatment or prognostication. If a negative prognosis is uncovered, there 
is time to involve palliative care, if desired, and allows family another opportunity 
for closure.
Some institutions have reported ECPR use as a temporary measure for organ 
perfusion while organ procurement organizations work to facilitate organ place-
ment [18, 19]. This is usually in situations where brain death is quickly identified 
after placement on ECMO. Viability of the organs is preserved, and the transplanted 
organs have a high rate of good functional recovery [20].
6. Application of ECPR
6.1 Process
The real-life application of ECPR varies between centers [21]. At a mini-
mum, a core group that consists of a code team, a cannulation team (surgeon 
Figure 1. 
Estimated survival rates for extracorporeal membrane oxygenation (ECPR) patients after every given low-flow 
time (red line). Survival with conventional CPR (dashes) is demonstrated as a comparison. Wengenmayer T, 
et al. Influence of low-flow time on survival after extracorporeal cardiopulmonary resuscitation Crit Care. 
2017;21(1):157. Published under terms of the Creative Commons Attribution 4.0 International License.
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or interventionalist to cannulate), and an ECMO specialist must be available. 
Support staff including additional nursing, pharmacy, and OR staff may be 
needed. Location of the cannulation procedure will depend on center experience 
and appropriateness of available space. For example, the procedure can happen in 
the intensive care unit, in the catheterization lab, or in the operating room. Some 
centers have reported experience with cannulating in other locations, such as in 
the emergency department, in the IR suite, or on regular hospital wards. Most 
reported experiences follow a similar algorithm.
6.2 ECMO cannulation
Cannulation technique for ECPR depends on anatomy, experience and train-
ing of the cannulating provider, and circumstances necessitating support [22]. In 
almost all cases, ECPR patients require VA cannulation. If the patient has an open 
sternum, central cannulation is the easiest approach. In smaller children, the right 
carotid artery and internal jugular vein are the most common choice. In adults and 
adult-sized children, femoral cannulation is technically feasible. Femoral cannula-
tion can limit the no-flow time due to minimal or no interruptions in compressions. 
Placed cannulas should support at least 120-150 mL/kg/min flow in order to pro-
vide an appropriate cardiac index in smaller children. In larger children and adults, 
the cannulas should support 3.5 to 5 L/min depending on the underlying etiology 
of cardiac arrest. If cannula sizes are deemed to be insufficient for flow, additional 
venous drainage can be added.
6.3 Initial management: post arrest care
The goal of post arrest care is to safeguard neurologic function and prevent 
secondary organ injury, while working towards the diagnosis and management of 
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the cause of arrest. The AHA recommends adopting a systems-based, protocolized, 
goal-directed approach to the management of post-arrest patients [23]. This 
includes ECPR patients.
Table 1 highlights the most important care recommendations from the AHA, 
and Table 2 includes monitoring modalities to be considered. These are based on 
the best available evidence, which may be limited to expert opinion in some cases. 
All recommendations are continuously reviewed and updated by the AHA as more 
evidence becomes available.
6.4 Initial management: A systems approach
Critical care management of post-ECPR ECMO patients should involve a multi-
disciplinary team that includes ECMO nurse/therapist, bedside staff, intensivists, 
and surgeons. Post arrest management should be implemented per local protocols. 
Like all ECMO patients, sedation, ventilation, anticoagulation, nutrition, and infec-
tion control should be cautiously monitored:
1. Neurological/Sedation: Soon after resuscitation, it is imperative to determine 
the patient’s neurologic status, as this will guide further decision making 
Continuous telemetry Assists with close monitoring of rhythm status
Exhaled CO2 monitor Allows for capturing CO2 changes early
Continuous pulse oximetry Assists with maintaining normoxia
Cerebral NIRS (near-infrared 
spectrometry) monitor
May be useful in identifying periods of increased vulnerability to 
developing neurologic injury [28]
Electroencephalogram (EEG) Discontinuous or isoelectric tracings are associated with worse 
neurologic outcome. EEG data in this setting is limited but may be 
useful in prognostication in consort with other criteria.
Arterial blood pressure monitor Assists with close monitoring of hemodynamics thus avoiding 
hypotension
Central venous pressure monitor Assists with assessment of volume status
Continuous temperature monitor Rectal or bladder monitor: may allow for capturing temperature 
changes early
Table 2. 
Monitoring modalities.
Management goal Reasoning
Maintain normal 
oxygenation
Elevated PO2 contributes to oxidative stress, and adult studies associate 
hyperoxia with decreased survival [24]. Hypoxia is associated with worse 
neurologic and overall outcomes.
Maintain normocarbia Hypocapnia has been associated with worse outcomes in adults, and hypercapnia 
has been associated with decreased survival in pediatrics [24].
Maintain 
normotension
Post-ROSC hypotension is associated with decreased survival to discharge and 
worse neurologic outcomes [25]. Severe hypertension may adversely affect 
cardiac output, and has also been associated with neurologic injury [26].
Targeted temperature 
management
Aggressively avoid hyperthermia, which is associated with poor outcomes [27]. 
At this time, there is insufficient evidence to recommend hypothermia over 
goal-directed normothermia.
Table 1. 
Post arrest care.
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and management. Close monitoring of the neurologic exam is imperative. 
Evaluate for signs of seizures, and EEG should be obtained if there is any 
suspicion. Near-infrared spectroscopy (NIRS) monitors can be used to follow 
cerebral oxygenation, possibly serving as an indicator of neurological activity 
and overall perfusion. In infants, routine bedside head ultrasounds should 
be considered, since these are simple and inexpensive assessments that can 
provide important information about development of neurologic injury. For all 
patients, head imaging such as with computed topography should be consid-
ered as indicated by exam and other clinical findings. Analgesia and sedation 
should be appropriately used to provide comfort; muscle relaxants use should 
be minimized to cases of safety or medical concerns.
2. Cardiovascular: Continuous cardiac and hemodynamic monitoring is impor-
tant. Peripheral perfusion should be monitored, especially in patients with 
femoral cannulation. Volume must be judiciously used to maintain cardiac 
preload. Systemic vascular resistance should be balanced to the patient’s needs, 
with judicious use of inotropy if cardiac contractility needs augmentation. 
All patients should be monitored for need for LV decompression as discussed 
below. In patients with absent pulsatility, the LV must be monitored for clot 
formation.
3. Pulmonary: Maintain functional residual capacity to facilitate oxygenation 
of pulmonary blood flow, balancing that with allowing for lung rest. Gentle 
pulmonary toilet is warranted, balancing secretion clearance with avoiding 
trauma and bleeding.
4. Gastrointestinal/Renal: Nutrition should be considered as indicated; we 
promote early enteral feeding if able. Gastric drainage and stool output must 
be monitored for bleeding. Urine output should be monitored closely, with 
promotion of diuresis as needed. In case of renal failure, hemofiltration or 
dialysis must be considered.
5. Infection: Routine indicators of infection are unreliable: vital signs are influ-
enced or controlled by the circuit, and lab parameters can be affected by the 
circuit. Assessment of the patient must include diligent monitoring of all sites 
of cannula or line insertion, as well as all wounds. Routine monitoring of CBC 
with differential is recommended. Surveillance cultures, as well as antibiotic 
prophylaxis, should be done per institutional protocol.
6.5 Initial management: Anticoagulation
Most ECMO centers have their own institutional protocols for ECMO anticoagu-
lation, usually an amalgam of center experience, ELSO guidelines, and published 
literature. We suggest utilizing an anticoagulation expert when setting up such a 
protocol, and recommend reviewing institutional practices regularly with the goal 
of keeping up-to-date with the literature.
Anticoagulation in this patient population starts with the cannulation procedure. 
A bolus of unfractionated heparin (typically 50–100 units per kg) is given directly 
to the patient prior to cannula placement. Afterwards, an unfractionated heparin 
infusion is started, usually 28–30 units/kg/hr. in neonates and infants, and 20 units/
kg/hr. in larger children. Of note, neonates may need higher doses of unfraction-
ated heparin secondary to naturally lower antithrombin III (ATIII) plasma concen-
trations. Less heparin may be required in patients who have a coagulopathy.
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Anticoagulation monitoring differs between centers [29, 30]. Labs can include 
partial thromboplastin time (PTT), anti-Xa, and thromboelastography (TEG). ATIII 
levels may be monitored dependent on the clinical situation. Platelets, fibrinogen, 
and plasma free hemoglobin are adjunct values that can be monitored, and can help 
with management of a circuit’s anticoagulation. The patient’s coagulable state must 
be taken into consideration, and this may alter dosing and target lab values. Table 3 
lists the most common parameters used in monitoring anticoagulation.
Some centers report the use of direct thrombin inhibitors, such as bivalirudin, as 
an alternative to unfractionated heparin infusions [31]. Direct thrombin inhibitors 
(DTI) have the advantage of not requiring ATIII for action and can inhibit clot-
bound thrombin. However, DTIs do not act on the contact pathway, which may be 
an issue in low-flow parts of a circuit (such as a bridge or a pigtail for lab draws). 
DTIs are titrated to a PTT of 1.5–2 times normal, and so it is important to establish a 
baseline value prior to use.
6.6 Special consideration: left heart decompression
Patients managed with ECMO, more so in the setting of cardiac disease or 
ECPR, can develop myocardial dysfunction and left heart failure [32]. In ECMO 
patients who develop poor left heart function, the team must work to offload the 
heart [33]. This is necessary to prevent complications such as worsening cardiac 
function or pulmonary edema [34].
Management of ECMO-related LV distension should start with exclusion of poor 
cannula positioning and eliminating mechanical issues with the ECMO circuit [35]. 
Pump function should be adjusted to maintain appropriate flows. LV distension can 
be secondary to volume overload, and so volume status should be addressed accord-
ingly. In case of poor cardiac muscle function, inotropes to improve contractility 
and vasodilators to decrease LV afterload can be utilized.
If offloading the left heart cannot be achieved medically, and cardiac output 
remains compromised, the institution of an interventional approach may be 
required. Several interventional decompression strategies have been described and 
are listed in Table 4. Evidence-based guidelines are lacking with regards of absolute 
indications, timing of intervention, and management method. The following is a 
non-comprehensive list of indications from the literature:
1. Elevated LA pressure and LVEDP despite maximal medical management
2. Severe distension of LA or LV (can include LV thrombus in setting of stasis)
3. Poor left outflow tract ejection/closed aortic valve
4. Refractory pulmonary edema or pulmonary hemorrhage
5. Aortic valve regurgitation
6. Elevated LV wall stress
7. LV or RV dysfunction
6.7 ECPR program
Several authors have discussed the essential components of an ECMO program, 
which are needed before ECPR can be offered as a treatment option [21, 47]. With 
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ECPR, time is of the essence. In order to successfully offer ECPR, a well-established 
protocol needs to be in-place and needs to be followed each time. There are several 
reported characteristics of a successful ECPR program, independent of the qual-
ity and capability of the ECMO team. An ideal team should be able to respond to 
situations in a consistent manner while maintaining that quality despite negative 
situations or hardship.
Consistency is maintained by continued training of all members of the team. 
Ongoing training must be both theoretical and hands-on. Simulation is a unique, 
effective way to incorporate the necessary training and dispense it to all members 
of the team in a way that can model real-life situations [48–52]. Leaders of the 
team must be able to keep up with the most up-to-date literature in ECMO and 
ECPR. Continued improvement of team performance is also assisted with maintain-
ing quality improvement projects focused on outcomes-based factors related to 
each institution. On-the-spot debriefing after each event is a good way to identify 
concerns that need to be addressed.
7. Complications
ECPR, like all other forms of extracorporeal life support, is associated with a 
host of mechanical and non-mechanical complications. Frequency and severity 
Strategy Reference
Intra-aortic balloon pump Aso et al. [36]
Pulmonary artery vent Fouilloux et al. [37]
Percutaneous trans-septal LA decompression Aiyagari et al. [38], O’Byrne et al. [39]
Trans-septal LA decompression with BAS and LA vent insertion Eastaugh et al. [40]
Transaortic vent Hong et al. [41]
Static over-the-wire balloon dilation Baruteau et al. [42], Eastaugh et al. [40]
Blade balloon septostomy Johnston et al. [43]
Atrial stenting Haynes et al. [44]
Direct surgical LA or LV venting Guirgis et al. [45], Sandrio et al. [46]
Table 4. 
Interventional decompression strategies for ECMO-related left heart dysfunction.
Lab parameter Description Goals
Activated Clotting Time (ACT) Assesses whole blood clotting Normal: 80–160 sec
ECMO target: 
180–240 seconds
Activated Partial Thromboplastin 
Time (aPTT)
Assesses the intrinsic pathway Normal: 30–40 sec ECMO 
target: 1.5x normal
Anti-Xa level Assesses clotting activity ECMO target: 
0.35–0.70 units/ml
Thromboelastography (TEG) Assessment of whole blood clotting, fibrinolysis and platelet 
activity
Table 3. 
Monitoring anticoagulation.
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for most ECPR-specific complications are not reported in the literature at this time 
–reports generally include all ECMO patients as a single group. The ELSO website 
has a comprehensive list of reported ECMO and ECPR complications, including 
mechanical, neurologic, cardiovascular, infectious, immunologic, hematologic, 
metabolic, pulmonary, and renal [53].
Here we will highlight some of the better studied complications.
7.1 Neurologic complications
Neurologic complications on ECMO have been extensively documented due to 
their significant burden and influence on outcomes. In pediatric patients treated 
with ECMO, there is a 7% prevalence of intracranial hemorrhages and a 6% preva-
lence of cerebral infarctions. Overall ECMO survival drops by half in patients who 
develop neurological injury. Survivors have multiple long-term morbidities, includ-
ing seizures and global developmental delay.
ECPR specific neurologic injuries are more prevalent and more significant than with 
routine ECMO. The ELSO database reports 12% incidence of seizures, 11.8% incidence 
of hemorrhage or infarct, and 11% incidence of brain death. Hemorrhages and infarcts 
were associated with lower survival. Severe acidosis, non-cardiac arrest etiology, and on 
ECMO CPR were risk factors for the neurologic injuries. Unfortunately, registry datasets 
are not granular and more specific associations are difficult to identify.
Literature reporting of neurodevelopmental outcomes post ECMO and ECPR 
is limited, and there is a varied approach to assessment and documentation [54]. 
However, overall trends appear encouraging. Favorable neurologic outcomes have 
been shown in up-to 65% of ECPR survivors. Favorable outcomes in these reports 
are defined as normal function or mild cerebral disability, showing that a good 
quality of life is attainable for arrest patients treated with ECPR. Further work is 
needed to uncover determinants of good outcomes.
7.2 Acute kidney injury and renal replacement therapy
Acute kidney injury (AKI) is common in critically ill patients, and patients 
treated with ECMO are especially prone to developing AKI. ECMO patients with AKI 
and subsequent fluid overload have a higher risk of longer ECMO runs and greater 
mortality [7]. Fluid overload management differs between centers, and includes fluid 
restriction, diuresis, slow continuous ultrafiltration (SCUF). None of these methods 
are efficient in removing solutes, and so continuous renal replacement therapy may 
be needed when fluid overload coincides with AKI. It should be noted that aggressive 
early CRRT may be associated with worse outcome [55], and indicates that judicious 
fluid management must always be an ongoing balance tailored to each patient.
8. Outcomes
ECPR is superior to conventional CPR. Overall survival to discharge in 
pediatric patients treated with ECPR in the ELSO registry is approximately 
40%; Table 5 shows a breakdown of this data. Other reports of ECPR survival 
vary across the literature, and the quoted numbers range between 23%-55%. In 
contrast, overall reported survival rates for conventional CPR in pediatrics range 
between 16 to 30%. The large range of variability is due to differences between 
institutional experience, expertise, and reporting on these patients. Superior 
survival rates persist with longer term follow-up and have been demonstrated 
up-to 12 months after discharge.
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A major indicator of quality of life in survivors of ECPR is neurologic outcome. 
While work is limited, there is indication that these outcomes may be positive, and 
perhaps better than in patients rescued by conventional CPR. Several reviews have 
shown that survival with minimal neurologic damage was more frequent in patients 
rescued with ECPR. This trend remained true even after performing propensity 
score matching for patients across these groups.
8.1 Determining outcomes
Several pre-ECMO factors have been identified as important to determining 
outcomes of ECPR. Disease process leading to arrest is one such factor. Post-cardiac 
surgery patients, or patients who arrest in the setting of another primary cardiac pro-
cess, have consistently demonstrated the best survival when rescued with ECPR versus 
conventional CPR. Patients who arrest in the setting of neonatal respiratory disease 
also have favorable outcomes. Patients who arrest in the setting of sepsis have higher 
mortality rates than patients with a pure cardiac process, but have better survival than 
if managed with CPR alone [57]. Patients with arrest in the setting of a respiratory 
illness also do well [58]. Patients with gastrointestinal conditions, who are usually 
patients with complex multiorgan disorders, tend to have worse outcomes. Patients 
with oncologic disease and other immunosuppressed processes also do worse [15].
Time to full support is another important predictor of survival of patients res-
cued with ECPR [17]. Longer time spent in a low flow state is associated with drastic 
drops on survival to hospital discharge. Post-discharge, patients with longer low 
flow times have worse neurologic outcomes and higher post-discharge mortality. 
Duration in a low flow state is a highly modifiable factor, and should be minimized 
in order to achieve the best outcomes. It is important to establish ECMO candidacy 
for all high risk patients, so that ECMO can be deployed quickly in the setting of 
an arrest. In centers that offer ECPR, a rapid response team must be available at 
all times, in order to minimize the time needed to establish ECMO flow. This team 
must be highly trained and very adaptable, highlighting the need for an ongoing 
development program for any center that offers ECPR. In addition to the presence 
of a rapid response team, ECMO equipment must be readily available for utilization 
at all times. During the resuscitation, pauses in compressions are needed to allow 
for cannula insertion. Duration and frequency of such pauses must be limited as 
much as possible, since any no-flow time dramatically decreases survival as well.
It is important to note that prolonged resuscitation may not be futile if ECPR 
is utilized, highlighting the importance of choosing the right patients for ECPR 
therapy [59].
Location of arrest can influence survival. Arrests that occur in the intensive care 
unit, have the best outcomes post management with ECPR. Outside the intensive 
care unit, outcomes worsen, perhaps related to the quality of resuscitation provided 
and the duration it may take to establish access for ECMO. Locations where ECPR 
can be offered will be dependent on institutional logistics and resource availability. 
Regardless, there should be advance coordination to ensure the equipment and 
Total runs Survive ECLS Survival to discharge
Neonatal ECPR 1718 1140 (66%) 708 (41%)
Pediatric ECPR 3946 2262 (57%) 1675 (42%)
Total 5664 3402 (60%) 2383 (42%)
Table 5. 
ECPR runs per the ELSO database, 1990–2018 [56].
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personnel needed can be deployed smoothly. Literature has shown that it is possible 
to successfully offer ECPR in the emergency department with such arrangements.
On-ECMO complications also influence survival, regardless whether it is a planned 
run or ECPR [57]. Neurologic complications are associated with high mortality post-
ECPR. Inability to achieve and maintain adequate perfusion while on ECMO, noted 
by metabolic and lactic acidosis, has been tied to worse outcomes [60, 61]. Similarly, 
cardiac arrest during the ECMO run is also associated with poor outcomes. Renal 
failure and the need for renal replacement therapy have an association with inferior 
outcomes [58]. Severe coagulopathy and DIC also worsen survival – maintaining 
anticoagulation for the circuit and avoidance of fatal hemorrhage is a fine balance, and 
coagulopathy raises the risk of fatal hemorrhages [16, 62].
9. Special mention: out-of-hospital ECPR
Out of hospital cardiac arrests (OHCA) have very high mortality rates and very 
poor neurologic outcomes for both pediatric and adult patients [63, 64]. As a result, 
there has been growing interest in applying ECPR to OHCA. Overall survival rates 
vary for OHCA ECPR. Reported survival rates range from 12 to 30%, but patient 
numbers are very limited and there is extreme selection bias in this cohort [4]. 
ELSO reports that about half of all OHCA ECPR were reported in Europe, followed 
by the Asia-Pacific region, and lastly North America [65]. Almost all published 
experience is exclusively adult experience [66].
Application of ECPR for OHCA varies across different centers. Some institutions 
provide a “scoop and run” strategy, with quick transport to the emergency depart-
ment for cannulation in select patients with OHCA [67]. Other centers have a dif-
ferent approach, with the ability to “stay and treat” by initiating ECPR on the scene 
of the OHCA [68]. The different styles of application are dependent on availability 
of resources, feasibility, and local experience.
Provision of ECPR to OHCA presents challenges with cost-effectiveness, 
optimal candidacy, and timing of deployment. However, if done in settings with the 
appropriate resources utilizing an aggressive strategy with optimum patient selec-
tion, survival can possibly be favorable [14]. However, evidence remains inconclu-
sive and requires further study [66].
10. Conclusion and future directions
ECPR has emerged as an exciting rescue therapy, promising to improve out-
comes of cardiac arrest. It has shown superiority over conventional CPR, with 
better survival to discharge and better longer-term survival. It has also shown better 
neurologic outcomes. As overall experience grows, we expect to see increased uses 
and even better outcomes.
Nonetheless, this is an emerging field and there is a lot left to learn. Especially in 
pediatrics, knowledge gaps include:
1. Ideal ECPR candidacy
a. Definition of refractory arrest, i.e. how long should conventional CPR continue 
before ECPR should be considered
b. Inclusion and exclusion criteria for higher risk populations, including 
immunosuppressed patients and trauma patients
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c. Inclusion and exclusion criteria for out-of-hospital cardiac arrest
d. Assessment of futility in possible ECPR candidates
2. Team preparedness: specific nature of training to maintain ECPR team compe-
tency to decrease low flow time
3. Optimal approach to comprehensive post arrest care for ECPR patients
4. Approach to neuroprotection and neuroprognostication post-ECPR
5. Functional and neurodevelopmental post-discharge status of patients rescued 
with ECPR, and how to improve such outcomes
At this time, most ECMO and ECPR research is observational in nature. 
Generalization of pediatric data is hindered by the heterogeneity of patient ages and 
diagnosis, as well as variability of practice between different institutions. Because 
of the small numbers of patients overall and per institution, the field is ripe with 
opportunity for collaborative work. International registries and large research 
collaboratives may be able to provide enough patients to power larger investiga-
tions. More data will help empower decisions to treat children with ECPR, refine the 
caliber of care they receive, and improve their future quality of life.
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